A new study published in the JAMA has revealed that for patients with relapsing-remitting multiple sclerosis (RRMS), high-dose immunosuppressive therapy (HDIT) with autologous hematopoietic cell transplant (HCT) is related with sustained remission and improvements in neurologic function. Most patients with RRMS who received disease-modifying therapies experience breakthrough disease. Autologous (i.e. using a patient's own cells) HCT has been studied in RRMS with the ...
You have just read an article categorized health
titled Autologous Hematopoietic Cell Transplant (HCT) Sends Multiple Sclerosis into Remission.
Written by:
editor - Tuesday, December 30, 2014
There are currently no comments for "Autologous Hematopoietic Cell Transplant (HCT) Sends Multiple Sclerosis into Remission"
Post a Comment